Larylin Husten-Stiller Pastillen

Dropropizine, the active ingredient in Larylin Husten-Stiller Pastillen, is an antitussive presented as a lozenge for oral use. It suppresses cough and is intended for symptomatic relief in individuals with non‑productive cough.

GNH USA supplies Larylin Husten-Stiller Pastillen as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Dropropizine is used as an antitussive to alleviate cough associated with the respiratory tract.

- Acute upper‑respiratory infection cough: provides symptomatic relief of a sudden, non‑productive cough. - Acute bronchitis cough: reduces cough frequency and improves comfort during the inflammatory phase. - Post‑viral cough: helps calm lingering cough after viral upper‑respiratory infections.

Dropropizine may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Mild oral irritation: slight soreness or tingling in the mouth. - Taste disturbance: altered or unpleasant taste perception. - Nausea: occasional feeling of queasiness.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or angioedema. - Severe dizziness: pronounced vertigo or loss of balance. - Respiratory depression (very rare): marked reduction in breathing effort.

When using Dropropizine lozenges, consider the following safety measures.

- Pregnancy: consult a healthcare professional before use. - Breastfeeding: exercise caution and seek medical advice. - Children under 6 years: not recommended due to limited safety data. - Existing respiratory disease: monitor cough response closely. - Dizziness: avoid operating machinery if affected. - Store at ambient temperature: keep in the original pack, protect from moisture.

Dropropizine may interact with other medicines; awareness of the interaction level helps manage risk.

Major Interactions (Avoid): - Other central cough suppressants: additive suppression of cough reflex. - MAO inhibitors: potential enhancement of central effects. - Opioid analgesics: increased risk of respiratory depression.

Moderate Interactions (Monitor Closely): - Antihistamines: possible increased sedation. - Sedative agents (e.g., benzodiazepines): monitor for excessive drowsiness. - Alcohol: may potentiate central nervous system effects.